Sirolimus immunosuppression for liver transplantation in the presence of malignancy.

被引：0
|
作者：
Kneteman, NM
Bain, V
Babini, R
Meeberg, G
Shapiro, AMJ
Issa, S
Bigam, D
Ma, M
Gutfreund, K
Wong, WN
机构：
[1] Univ Alberta, Liver Transplant Program, Edmonton, AB, Canada
[2] Wyeth Ayerst Res, Canadian Ctr Clin Res & Dev, St Laurent, PQ, Canada
来源：
TRANSPLANTATION | 2000年 / 69卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
217
引用
收藏
页码：S170 / S170
页数：1
相关论文
共 50 条
  • [21] Long-Term Sirolimus for Primary Immunosuppression and Incidence of De Novo Malignancy Following Heart Transplantation
    Asleh, R.
    Li, X.
    Alnsasra, H.
    Briasoulis, A.
    Smith, B.
    Kremers, W.
    Pereira, N. L.
    Edwards, B. S.
    Daly, R. C.
    Stulak, J. M.
    Clavell, A.
    Kushwaha, S. S.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2019, 38 (04): : S274 - S274
  • [22] Sirolimus in liver transplantation
    Trotter, JF
    TRANSPLANTATION PROCEEDINGS, 2003, 35 (3A) : 193S - 200S
  • [23] The suspicion of malignancy.
    Lilienthal, H
    BOSTON MEDICAL AND SURGICAL JOURNAL, 1914, 170 : 120 - 123
  • [24] Early sirolimus immunosuppression is safe in lung transplantation
    Wojarski, Jacek
    Zeglen, Slawek
    Ochman, Marek
    Karolak, Wojtek
    Zembala, Marian
    EUROPEAN RESPIRATORY JOURNAL, 2012, 40
  • [25] Immunosuppression with sirolimus, cyclosporyne, and prednisone in renal transplantation
    Gonzalez-Posada, JM
    Rodriguez, AP
    Pérez-Tamajón, L
    Hdez-Marrero, D
    Maceira, B
    TRANSPLANTATION PROCEEDINGS, 2002, 34 (01) : 99 - 99
  • [26] Conversion to sirolimus immunosuppression in liver transplantation recipients with hepatocellular carcinoma:Report of an initial experience
    Jian Zhou
    World Journal of Gastroenterology, 2006, (19) : 3114 - 3118
  • [27] Sirolimus-based immunosuppression in liver transplantation for hepatocellular carcinoma: A meta-analysis
    Liang, Wenhua
    Wang, Dongping
    Ling, Xiaoting
    Kao, Andrew Allen
    Kong, Yuan
    Shang, Yushu
    Guo, Zhiyong
    He, Xiaoshun
    LIVER TRANSPLANTATION, 2012, 18 (01) : 62 - 69
  • [28] Primary sirolimus based immunosuppression allows delayed use of CNI in liver transplantation.
    Lorf, T
    Weichhold, HE
    Binder, L
    Ramadori, G
    Quintel, M
    Becker, H
    LIVER TRANSPLANTATION, 2005, 11 (07) : C44 - C44
  • [29] Evaluating sirolimus-based immunosuppression for the prevention of cytomegalovirus replication after liver transplantation
    Arasaratnam, R. J.
    CLINICAL TRANSPLANTATION, 2015, 29 (09) : 723 - 723
  • [30] Conversion to sirolimus immunosuppression in liver transplantation recipients with hepatocellular carcinoma: Report of an initial experience
    Zhou, Jian
    Fan, Jia
    Wang, Zheng
    Wu, Zhi-Quan
    Qiu, Shuang-Jian
    Huang, Xiao-Wu
    Yu, Yao
    Sun, Jian
    Xiao, Yong-Sheng
    He, Yi-Feng
    Wang, Yu-Qi
    Tang, Zhao-You
    WORLD JOURNAL OF GASTROENTEROLOGY, 2006, 12 (19) : 3114 - 3118
12345